Heterocyclic compounds for the inhibition of PASK
Disclosed herein are new heterocyclic compounds and compositions and their application as pharmaceuticals for the treatment of disease. Methods of inhibiting PAS Kinase (PASK) activity in a human or animal subject are also provided for the treatment of diseases such as diabetes mellitus.
Saved in:
| Format | Patent |
|---|---|
| Language | English |
| Published |
16.01.2018
|
| Online Access | Get full text |
Cover
Loading…
| Summary: | Disclosed herein are new heterocyclic compounds and compositions and their application as pharmaceuticals for the treatment of disease. Methods of inhibiting PAS Kinase (PASK) activity in a human or animal subject are also provided for the treatment of diseases such as diabetes mellitus. |
|---|